iShares Morningstar Small-Cap ETF (ISCB) offers a lower expense ratio and a higher trailing-12-month dividend yield than JPMorgan BetaBuilders U.S. Small Cap Equity ETF.
JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) delivered higher 1-year total returns, but carries a higher beta relative to the S&P 500.
ISBC maintains a significantly broader portfolio with nearly twice as many individual holdings as BBSC.
The choice between the JPMorgan BetaBuilders U.S. Small Cap Equity ETF (NYSEMKT:BBSC) and the iShares Morningstar Small-Cap ETF (NYSEMKT:ISCB) comes down to a familiar investing trade-off: concentrated recent performance versus broader, lower-cost diversification.
Small-capitalization stocks offer significant growth potential but often come with higher volatility than large-cap peers. Investors seeking small-cap exposure often look for low-cost, passively managed funds like these two.
| Metric | BBSC | ISCB |
|---|---|---|
| Issuer | J.P. Morgan | iShares |
| Expense ratio | 0.09% | 0.04% |
| 1-yr return (as of June 8, 2026) | 33.39% | 26.94% |
| Dividend yield | 1.03% | 1.27% |
| Beta | 1.32 | 1.17 |
| AUM | $732.6 million | $275.1 million |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
The iShares fund is the less expensive option, with a 0.04% expense ratio, compared to BBSC’s 0.09%. It also provides a higher dividend yield. For investors focused on long-term capital efficiency, that’s an attractive combination.
| Metric | BBSC | ISCB |
|---|---|---|
| Max drawdown (5 yr) | (30.97%) | (29.93%) |
| Growth of $1,000 over 5 years (total return) | ~$1,263 | ~$1,209 |
The iShares Morningstar Small-Cap ETF (ISCB) mirrors a benchmark of smaller U.S. companies, offering deep diversification through its 1,500+ holdings. Its portfolio leans toward industrials at 18%, with technology and financial services each representing 16%. Due to the large number of holdings, even the fund’s top individual positions are relatively small, which mitigates single-stock risk. Its largest positions include Lumentum Holdings Inc. (NASDAQ:LITE) at 0.98%, Revolution Medicines Inc. (NASDAQ:RVMD) at 0.47%, and Sterling Infrastructure Inc. (NASDAQ:STRL) at 0.42%.
The JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) offers a more concentrated profile with 700+ holdings, targeting companies in the 95th to 99th percentiles of available market capitalization. Like ISCB, the large number of holdings provides wide diversification, though BBSC maintains a heavier tilt toward technology at 20%, while financial services and healthcare account for 17% and 16%, respectively. Its largest positions include TTM Technologies Inc. (NASDAQ:TTMI) at 0.84%, SiTime Corp. (NASDAQ:SITM) at 0.78%, and Semtech Corp. (NASDAQ:SMTC) at 0.73%.
For more guidance on ETF investing, check out the full guide at this link.
Small-cap ETFs like ISCB and BBSC can play a meaningful role in a long-term portfolio, but the right choice depends on what you're actually trying to accomplish.
If you're drawn to BBSC's stronger recent returns, it's worth noting that performance also comes with a higher expense ratio, a heavier tech weighting, and greater sensitivity to market swings (higher beta). That tech tilt -- at 20% of the portfolio -- has worked in the fund's favor during periods of sector strength, but it also means more exposure when the segment pulls back. Small-cap tech names, in particular, tend to be more volatile than their large-cap counterparts.
ISCB, meanwhile, offers something that's easy to undervalue: a longer track record and a lower cost of ownership. Launched in 2004 -- sixteen years before BBSC -- it has navigated multiple market cycles, including the 2008 financial crisis and the 2020 pandemic crash, giving investors a much fuller picture of how the fund behaves under pressure. Add in the lower fee and higher trailing yield, and the math favors ISCB for patient investors who aren't chasing last year's performance
Neither fund is a bad choice for small-cap exposure. But history tends to reward investors who prioritize cost efficiency and diversification over concentrated short-term momentum. For most long-term investors, ISCB's profile looks like the more attractive choice.
Before you buy stock in iShares Trust - iShares Morningstar Small-Cap ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $445,672!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,280,566!*
Now, it’s worth noting Stock Advisor’s total average return is 948% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of June 10, 2026.
Andy Gould has positions in Lumentum and Sterling Infrastructure. The Motley Fool has positions in and recommends Lumentum, SiTime, and Sterling Infrastructure. The Motley Fool has a disclosure policy.